Moderna, State Street rise; FibroGen, Marten Transport fall

Stocks that traded heavily or had substantial price changes Friday:

Moderna Inc., up $26.76 to $286.43.

The biotechnology company will replace Alexion in the S&P 500 prior to July 21.

FibroGen Inc., down $10.49 to $14.35.

An FDA advisory committee recommended against approving the company’s treatment for anemia caused by kidney disease.

Marten Transport Ltd., down $1.01 to $15.80.

The trucking company’s second-quarter revenue fell short of Wall Street forecasts.

Boeing Co., down $5.02 to $217.74.

Federal regulators will require more frequent testing of switches on 737s that trigger warnings to pilots about cabin pressure loss.

Autoliv Inc., down $4.54 to $90.44.

The maker of auto safety systems reported disappointing second-quarter financial results.

Charles Schwab Corp., down $1.66 to $68.89.

The financial services company’s second-quarter profit fell short of analysts’ forecasts.

State Street Corp., up $2.37 to $84.34.

The regional bank beat Wall Street’s second-quarter profit and revenue forecasts.

People’s United Financial Inc., down 59 cents to $16.03.

The bank reported disappointing second-quarter revenue.

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up